FINCH THERAPEUTICS GROUP, INC. Retained Earnings
FINCH THERAPEUTICS GROUP, INC. had Retained Earnings of -$359.11 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-08-13
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$359.11M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$354.27M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$350.39M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$347.35M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-06-30 | -$359.11M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$354.27M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$350.39M 10-Q · filed 2024-08-13 |
| 2023-09-30 | -$347.35M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$344.94M 10-Q/A · filed 2023-08-11 |
| 2023-03-31 | -$339.58M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$275.64M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$248.63M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$208.26M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$185.56M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$161.00M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$141.94M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$131.99M 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$116.82M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$102.83M 10-K · filed 2022-03-31 |